Alexey Maschan Selected Research

Alexey Maschan Research Topics

Disease

5	Leukemia 04/2022 - 01/2020
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2022 - 01/2021
3	Philadelphia Chromosome 01/2022 - 12/2019
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 12/2016
2	Body Weight (Weight, Body) 06/2022 - 08/2021
2	Aplastic Anemia (Anemia, Hypoplastic) 04/2022 - 01/2022
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2022 - 11/2020
2	Wiskott-Aldrich Syndrome 01/2022 - 01/2021
2	Thrombocytopenia (Thrombopenia) 11/2021 - 01/2021
2	Headache (Headaches) 11/2021 - 01/2021
2	Hemorrhage 01/2021 - 11/2020
1	Neoplasms (Cancer) 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	WHIM syndrome 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Glioma (Gliomas) 01/2022
1	idiopathic Aplastic anemia 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Sepsis (Septicemia) 12/2021
1	Residual Neoplasm 12/2021
1	Liver Failure 12/2021
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2021
1	beta-Thalassemia (Cooley's Anemia) 11/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Fever (Fevers) 01/2021
1	Thrombotic Thrombocytopenic Purpura 01/2021
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 10/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Blast Crisis (Blast Phase) 12/2016
1	Proteus Syndrome 07/2015
1	Hodgkin Disease (Hodgkin's Disease) 07/2015
1	Fanconi Anemia (Fanconi's Anemia) 09/2011

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 01/2022 - 01/2019
3	romiplostim FDA Link 04/2022 - 11/2020
3	blinatumomabIBA 04/2022 - 01/2021
3	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 12/2016
2	plerixafor FDA Link 06/2022 - 08/2021
2	entrectinibIBA 01/2022 - 01/2021
2	Bortezomib (Velcade)FDA Link 01/2021 - 01/2020
2	nilotinib FDA Link 01/2021 - 12/2019
1	eltrombopag FDA Link 04/2022
1	Thrombopoietin ReceptorsIBA 04/2022
1	Inosine Triphosphate (ITP)IBA 04/2022
1	Thomsen-Friedenreich antibodiesIBA 01/2022
1	isatuximabIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	VemurafenibIBA 12/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2021
1	Cell-Free Nucleic AcidsIBA 12/2021
1	ruxolitinibIBA 11/2021
1	Filgrastim (Neupogen)FDA Link 08/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	TransferasesIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	BilirubinIBA 01/2021
1	AntigensIBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2020
1	GPI-Linked ProteinsIBA 10/2020
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 12/2019
1	Methotrexate (Mexate)FDA LinkGeneric 12/2016
1	Prednisolone (Predate)FDA LinkGeneric 12/2016
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 12/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2016
1	Asparaginase (Elspar)FDA Link 12/2016
1	Vincristine (Oncovin)FDA LinkGeneric 12/2016
1	Etoposide (VP 16)FDA LinkGeneric 12/2016
1	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2016
1	Brentuximab VedotinIBA 07/2015
1	fludarabineIBA 09/2011

Therapy/Procedure

5	Therapeutics 04/2022 - 07/2015
5	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2011
3	Drug Therapy (Chemotherapy) 01/2022 - 12/2016
2	Blood Component Removal (Apheresis) 06/2022 - 08/2021
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 09/2011
2	Aftercare (After-Treatment) 01/2022 - 12/2016
1	Immunotherapy 01/2022
1	Plasma Exchange 01/2021
1	Stem Cell Transplantation 01/2021
1	Transplantation 01/2020
1	Induction Chemotherapy 12/2016